Brad Watmuff
Brad Watmuff
Postdoctoral Fellow, Massachusetts General Hospital
Dirección de correo verificada de mgh.harvard.edu
TítuloCitado porAño
A Targeted NKX2.1 Human Embryonic Stem Cell Reporter Line Enables Identification of Human Basal Forebrain Derivatives
AL Goulburn, D Alden, RP Davis, SJ Micallef, ES Ng, QC Yu, SM Lim, ...
Stem cells 29 (3), 462-473, 2011
962011
Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning
CM Sellgren, J Gracias, B Watmuff, JD Biag, JM Thanos, PB Whittredge, ...
Nature neuroscience 22 (3), 374, 2019
372019
In vitro maturation of dopaminergic neurons derived from mouse embryonic stem cells: implications for transplantation
B Watmuff, CW Pouton, JM Haynes
PLoS One 7 (2), e31999, 2012
272012
Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells
B Watmuff, SS Berkovitch, JH Huang, J Iaconelli, S Toffel, R Karmacharya
Molecular and Cellular Neuroscience 73, 96-103, 2016
192016
Lysine deacetylation by HDAC6 regulates the kinase activity of AKT in human neural progenitor cells
J Iaconelli, J Lalonde, B Watmuff, B Liu, R Mazitschek, SJ Haggarty, ...
ACS chemical biology 12 (8), 2139-2148, 2017
132017
Unbiased metabolite profiling of schizophrenia fibroblasts under stressful perturbations reveals dysregulation of plasmalogens and phosphatidylcholines
JH Huang, H Park, J Iaconelli, SS Berkovitch, B Watmuff, D McPhie, ...
Journal of proteome research 16 (2), 481-493, 2016
82016
Human pluripotent stem cell derived midbrain PITX3eGFP/w neurons: a versatile tool for pharmacological screening and neurodegenerative modeling
B Watmuff, BJ Hartley, CPJ Hunt, SA Fabb, CW Pouton, JM Haynes
Frontiers in cellular neuroscience 9, 104, 2015
82015
Perturbational profiling of metabolites in patient fibroblasts implicates α-aminoadipate as a potential biomarker for bipolar disorder
JH Huang, SS Berkovitch, J Iaconelli, B Watmuff, H Park, ...
Molecular neuropsychiatry 2 (2), 97-106, 2016
42016
Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder
B Watmuff, B Liu, R Karmacharya
Pharmacogenomics 18 (5), 471-479, 2017
22017
Pluripotent stem cell-derived dopaminergic neurons as models of neurodegeneration
B Watmuff, BJ Hartley, CP Hunt, CW Pouton, JM Haynes
Future Neurology 8 (6), 649-661, 2013
12013
S193. EX VIVO SIGNATURE OF PSYCHOSIS AND TREATMENT RESPONSE IN PATIENT-DERIVED NEURONS
R Karmacharya, B Watmuff, A Kathuria, B Liu
Schizophrenia bulletin 44 (Suppl 1), S400, 2018
2018
Interrogating disease biology of bipolar disorder using patient-derived cells
R Karmacharya, B Watmuff, B Liu, A Kathuria
BIPOLAR DISORDERS 20, 9-9, 2018
2018
Increased microglial synapse elimination in patient-specific models of schizophrenia
CM Sellgren, J Gracias, B Watmuff, CP Goold, JM Thanos, T Fu, ...
bioRxiv, 231290, 2017
2017
In vitro Differentiation of Pluripotent Stem Cells towards either Forebrain GABAergic or Midbrain Dopaminergic Neurons
BJ Hartley, B Watmuff, CPJ Hunt, JM Haynes, CW Pouton
Neural Stem Cell Assays, 91-99, 2015
2015
Genetic Reporter Cell Lines: Tools for Stem Cell Biology and Drug Discovery
CPJ Hunt, B Watmuff, BJ Hartley, CW Pouton, JM Haynes
Neural Stem Cell Assays, 251-260, 2015
2015
Functional Development of Embryonic Stem Cell-derived Midbrain Dopaminergic Neurons
B Watmuff
Monash University, 2014
2014
GABA Modulation of Activity in Dopaminergic Neurons Derived from Mouse Embryonic Stem Cells
B Watmuff
Monash University, 2008
2008
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–17